Acyclovir Dosing for Herpes Zoster
For herpes zoster (shingles), the recommended dose is acyclovir 800 mg orally 5 times daily for 7-10 days, initiated within 72 hours of rash onset for maximum benefit. 1, 2, 3
Oral Therapy Regimen
Standard Dosing
- Acyclovir 800 mg orally 5 times daily for 7-10 days is the established regimen for immunocompetent adults with herpes zoster 1, 2, 3
- The 800 mg dose is superior to lower doses (400 mg showed no significant benefit over placebo) 3
- Treatment must be started within 72 hours of rash onset; starting after 48 hours significantly reduces efficacy 2
Clinical Benefits of Treatment
- Accelerates resolution of rash with faster time to crusting and healing 1, 2, 3
- Reduces duration and severity of acute pain during the first 2-10 days of treatment 2, 3
- Decreases new lesion formation and prevents dissemination to adjacent dermatomes 1, 3
- May reduce the prevalence of post-herpetic neuralgia in the first 3 months, though this benefit is modest 1, 3
Intravenous Therapy for Severe Disease
When to Use IV Acyclovir
- For severe disease, complications, or hospitalized patients: acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical improvement 4
- IV therapy is indicated for immunocompromised patients, disseminated zoster, or CNS involvement 5
- The higher dose (10 mg/kg) is preferred given that varicella-zoster virus is less sensitive to acyclovir than herpes simplex virus 5
Critical Safety Considerations with IV Therapy
- Maintain adequate hydration and urine flow to prevent crystalluria 5
- Monitor mental status as neurotoxicity can occur 5
- Adjust dosing downward in renal impairment 5
Alternative Agent: Valacyclovir
- Valacyclovir 1000 mg orally 3 times daily for 7 days offers superior convenience with equivalent or better efficacy compared to acyclovir 6
- Valacyclovir provides 3-5 fold higher bioavailability than acyclovir, allowing less frequent dosing 6
- It significantly accelerates resolution of pain (median 38 days vs 51 days with acyclovir) and reduces post-herpetic neuralgia duration 6
Special Populations
Immunocompromised Patients
- Require more aggressive therapy with higher doses or IV administration 7, 4
- May need suppressive therapy with acyclovir 400 mg orally 3-5 times daily 4
- Higher risk of acyclovir-resistant strains, which require foscarnet 40 mg/kg IV 3 times daily or 60 mg/kg IV twice daily 4
Common Pitfalls to Avoid
- Never use topical acyclovir for herpes zoster—it is substantially less effective than oral therapy 7
- Do not delay treatment beyond 72 hours of rash onset, as efficacy drops significantly 2
- The 400 mg dose is inadequate for herpes zoster (unlike herpes simplex) and should not be used 3
- Acyclovir does not eradicate latent virus and does not prevent future recurrences 7